Teladoc Health (TDOC) Net Cash Flow (2014 - 2026)

Teladoc Health has disclosed Net Cash Flow across 13 years of filings, most recently posting -$29.5 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$29.5 million, up 72.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$446.2 million (down 563.79% YoY), and the FY2025 annual result was -$523.3 million, down 394.09% from the prior year.
• Net Cash Flow came in at -$29.5 million for Q1 2026 at Teladoc Health, down from $54.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $91.8 million in Q4 2023 to a low of -$518.2 million in Q2 2025.
• The 5-year median for Net Cash Flow is $46.3 million (2022), against an average of -$8.4 million.
• Across the five-year window, Net Cash Flow surged 472.36% in 2023 and slumped 900.43% in 2025, its largest moves.
• Teladoc Health's Net Cash Flow stood at $16.0 million in 2022, then soared by 472.36% to $91.8 million in 2023, then tumbled by 36.48% to $58.3 million in 2024, then dropped by 6.5% to $54.5 million in 2025, then tumbled by 154.02% to -$29.5 million in 2026.
• The last three Net Cash Flow figures came in at -$29.5 million (Q1 2026), $54.5 million (Q4 2025), and $47.0 million (Q3 2025), per Business Quant data.